The Corona Vaccine, developed by Synovac to prevent code 19, is currently being used extensively in Pakistan.
In Pakistan, the government has so far not released any data on the prevention of this vaccine, but the Latin American country of Chile has compared the effectiveness of the vaccine developed by Synovac with Pfizer and AstraZeneca vaccines.
According to data released by Chile, Cinnabac’s Code 19 vaccine is 58.5% effective in providing protection against symptomatic disease in real life.
In comparison, the Pfizer vaccine was 87.7% effective and the AstraZeneca vaccine was 68.7% effective.
The data, compiled from the vaccinations of millions of Chileans between February and July, is a new statistic for the real-life benefits of vaccines in Chile.
A vaccination campaign against Cod 19 was launched in Chile in December 2020 and so far more than 60% of the population has been vaccinated, most of whom have been vaccinated with the cyanobacterial vaccine.
According to data released by Chilean authorities on August 3, the synovac vaccine proved to be 86% effective in preventing hospital admissions from February to July, 89.7% in preventing ICU admissions and 86% in preventing deaths Happened.
Earlier, data was released by Chile from February to May 2021, during which time Corona’s Alpha (which first appeared in the UK) and Gemma (which appeared in Brazil and P1 Types of cases were also coming to the fore.
It was reported on the occasion that people who consume 2 doses of Corona Week prepared by Sino Week get up to 66% protection from the disease.
In contrast, those who complete the Pfizer vaccination have up to 93% protection.
Preliminary data from the Chilean study, released in April, found that Corona Week’s use provides a 67% protection against cod symptoms and an 80% reduction in mortality.
Chilean officials have released new data, saying a reduction in vaccine protection rates is inevitable over time, especially as more contagious species, such as deltas, are spreading rapidly.
He said that if the Delta variety spreads more rapidly and the response to vaccines weakens, their efficacy rate may decline sharply, but in that case a third dose of the vaccine may be given.
The Chilean government also released data on the effectiveness of the Pfizer and AstraZeneca vaccines.
According to the data, the Pfizer vaccine is 87.7% effective in preventing symptomatic disease, 98% effective in preventing ICU admission and 100% effective in preventing deaths.
Similarly, the AstraZeneca vaccine proved to be 68.7% effective in preventing symptomatic disease, 98% effective in preventing ICU admission and 100% effective in preventing deaths.
The Chilean study examined the effectiveness of vaccines in people from a variety of walks of life who were either given two doses or one dose of a specific vaccine or were not vaccinated.
So far, 8.6 million people in Chile have been vaccinated with the synovic vaccine, 4.5 million with the Pfizer vaccine and 2.3 million with the astraZeneca vaccine.